Trial intelligence / Profile preview

Vitamin D in Active Rheumatoid Arthritis

NCT04472481Phase 4Completed

Sponsor
Tanta University
Start
Sep 2019
Primary completion
Dec 2019
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised trial of vitamin d in rheumatoid arthritis (RA) (3 arms), sponsored by Tanta University. Primary endpoint: Regulatory T cells (CD4+CD25+FoxP3+) at 3 months. Started Sep 2019; status: completed.

02

Drugs

vitamin d
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT04472481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04472481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call